Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FibroGen (FGEN)

FibroGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FGEN
DateTimeSourceHeadlineSymbolCompany
10/01/202523:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
18/12/202422:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
16/12/202414:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
16/12/202413:05GlobeNewswire Inc.FibroGen Appoints David DeLucia as Chief Financial OfficerNASDAQ:FGENFibroGen Inc
10/12/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
10/12/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
10/12/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
14/11/202421:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FGENFibroGen Inc
12/11/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FGENFibroGen Inc
12/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
12/11/202421:05GlobeNewswire Inc.FibroGen Reports Third Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
04/11/202421:05GlobeNewswire Inc.FibroGen to Report Third Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
03/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
16/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
13/09/202420:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
10/09/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
10/09/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
10/09/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
06/09/202420:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
03/09/202420:05GlobeNewswire Inc.FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FGENFibroGen Inc
07/08/202421:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FGENFibroGen Inc
07/08/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
06/08/202420:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FGENFibroGen Inc
06/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
06/08/202420:05GlobeNewswire Inc.FibroGen Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FGENFibroGen Inc
05/08/202420:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
30/07/202420:07GlobeNewswire Inc.FibroGen to Report Second Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
30/07/202420:05GlobeNewswire Inc.FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate UpdateNASDAQ:FGENFibroGen Inc
11/07/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FGENFibroGen Inc
08/07/202420:32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FGENFibroGen Inc
 Showing the most relevant articles for your search:NASDAQ:FGEN